How can patients be advised about working with medical conditions?
Trial results of idelalisib with bendamustine and rituximab in CLL
Two important therapies for ALL
Potential combination of ibrutinib with gamma delta T-cell therapy in CLL
Iris de Weerdt
The IFM 2012-03 trial: what will the next step be?